(Q45036323)

8 December 2017

Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus (English)

1 reference

8 December 2017

1 reference

Yi-Chih Hung

1

1 reference

8 December 2017

Che-Chen Lin

2

1 reference

8 December 2017

Tzu-Yuan Wang

3

1 reference

8 December 2017

Man-Ping Chang

4

1 reference

8 December 2017

Fung-Chang Sung

5

1 reference

8 December 2017

Ching-Chu Chen

6

1 reference

8 December 2017

1 November 2013

1 reference

Diabetes - Metabolism: Research and Reviews

8 December 2017

1 reference

8 December 2017

29

1 reference

8 December 2017

8

1 reference

8 December 2017

673-679

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

8 December 2017

1 reference

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

UKPDS and the legacy effect.

21 January 2018

1 reference

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

21 January 2018

1 reference

Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction

21 January 2018

1 reference

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

21 January 2018

1 reference

Oral antihyperglycemic therapy for type 2 diabetes mellitus.

21 January 2018

1 reference

The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury

21 January 2018

1 reference

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

National trends in treatment of type 2 diabetes mellitus, 1994-2007

21 January 2018

1 reference

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

21 January 2018

1 reference

A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin

21 January 2018

1 reference

Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.2444

1 reference

8 December 2017

1 reference